V. Yewale and D. Dharmapalan, Promoting Appropriate Use of Drugs in Children, International Journal of Pediatrics, vol.25, issue.1, pp.1-5, 2012.
DOI : 10.1001/archpedi.161.3.282

K. Allegaert, . Van-den, and J. Anker, Adverse drug reactions in neonates and infants: a population-tailored approach is needed, British Journal of Clinical Pharmacology, vol.309, issue.4, pp.788-95, 2015.
DOI : 10.1001/jama.2013.3411

J. Mason, M. Pirmohamed, and T. Nunn, Off-label and unlicensed medicine use and adverse drug 500003066.pdf 90. WHO. Paediatric clinical trials guidance for assessors, 2011.

A. Lajoinie, E. Henin, K. Nguyen, S. Malik, Y. Mimouni et al., Oral drug dosage forms administered to hospitalized children: Analysis of 117,665 oral administrations in a French paediatric hospital over a 1-year period., International Journal of Pharmaceutics, vol.500, issue.1-2, pp.336-380, 2016.
DOI : 10.1016/j.ijpharm.2016.01.048

A. Ali, N. Charoo, and D. Abdallah, Pediatric drug development: formulation considerations, Drug Development and Industrial Pharmacy, vol.67, issue.10, pp.1-17, 2014.
DOI : 10.1016/j.ejpb.2012.01.014

T. Ernest, J. Craig, A. Nunn, S. Salunke, C. Tuleu et al., Preparation of medicines for children ??? A hierarchy of classification, International Journal of Pharmaceutics, vol.435, issue.2, pp.124-154, 2012.
DOI : 10.1016/j.ijpharm.2012.05.070

J. Breitkreutz and J. Boos, Paediatric and geriatric drug delivery, Expert Opinion on Drug Delivery, vol.67, issue.1, pp.37-45, 2007.
DOI : 10.1055/s-2005-870129

J. Krause and J. Breitkreutz, Improving Drug Delivery in Paediatric Medicine, Pharmaceutical Medicine, vol.8, issue.2, pp.41-50, 2008.
DOI : 10.1016/j.prrv.2007.02.005

S. Montero-padilla, S. Velaga, and J. Morales, Buccal Dosage Forms: General Considerations for Pediatric Patients, AAPS PharmSciTech, vol.18, issue.2, pp.1-10, 2016.
DOI : 10.1208/s12249-016-0567-2

J. Krause and J. Blackburn, Novel Paediatric Formulations for the Drug Sodium Benzoate Available from: http://docserv.uniduesseldorf .de/servlets A Review of Medication Dosage Forms , Drug Administration , Pharmacokinetics , and Abbreviations Statement of Need. Rev Lit Arts Am, 2008.

E. Yi, J. Kim, Y. Rhee, S. Kim, H. Lee et al., Preparation of sildenafil citrate microcapsules and in vitro/in vivo evaluation of taste masking efficiency, International Journal of Pharmaceutics, vol.466, issue.1-2, pp.286-95, 2014.
DOI : 10.1016/j.ijpharm.2014.03.001

J. Standing and C. Tuleu, Paediatric formulations???Getting to the heart of the problem, International Journal of Pharmaceutics, vol.300, issue.1-2, pp.56-66, 2005.
DOI : 10.1016/j.ijpharm.2005.05.006

R. Arora, U. Mukherjee, and V. Arora, Erosive Potential of Sugar Free and Sugar Containing Pediatric Medicines Given Regularly and Long Term to Children, The Indian Journal of Pediatrics, vol.39, issue.6, pp.759-63, 2012.
DOI : 10.1590/S0034-89102005000300022

J. Walsh, A. Cram, K. Woertz, J. Breitkreutz, G. Winzenburg et al., Playing hide and seek with poorly tasting paediatric medicines: Do not forget the excipients, Advanced Drug Delivery Reviews, vol.73, pp.14-33, 2014.
DOI : 10.1016/j.addr.2014.02.012
URL : http://doi.org/10.1016/j.addr.2014.02.012

A. Vinks, C. Emoto, and T. Fukuda, Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children, Clinical Pharmacology & Therapeutics, vol.67, issue.Suppl. 3, pp.298-308, 2015.
DOI : 10.1080/15287390490273550

S. Gandhi, W. Rodriguez, M. Khan, and J. Polli, Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs, AAPS PharmSciTech, vol.15, issue.3, pp.601-612, 2014.
DOI : 10.1208/s12249-014-0084-0

S. Abdul, A. V. Chandewar, and S. Jaiswal, A flexible technology for modified-release drugs: Multiple-unit pellet system (MUPS), Journal of Controlled Release, vol.147, issue.1, pp.2-16, 2010.
DOI : 10.1016/j.jconrel.2010.05.014

X. Tan and J. Hu, Investigation for the quality factors on the tablets containing medicated pellets, Saudi Pharmaceutical Journal, vol.24, issue.5
DOI : 10.1016/j.jsps.2015.01.020

A. Hosseini, M. Körber, and R. Bodmeier, Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile, International Journal of Pharmaceutics, vol.457, issue.2, pp.503-512, 2013.
DOI : 10.1016/j.ijpharm.2013.07.042

D. Ghanam and P. Kleinebudde, Suitability of a flat die press for the manufacture of pharmaceutical pellets by extrusion/spheronization, Drug Development and Industrial Pharmacy, vol.7, issue.4, pp.456-64, 2011.
DOI : 10.1016/j.ejpb.2005.10.003

G. Tomer, F. Podczeck, and J. Newton, The influence of model drugs on the preparation of pellets by extrusion/spheronization: II spheronization parameters, International Journal of Pharmaceutics, vol.231, issue.1, pp.107-126, 2002.
DOI : 10.1016/S0378-5173(01)00876-6

R. Chopra, F. Podczeck, J. Newton, and G. Alderborn, The influence of pellet shape and film coating on the filling of pellets into hard shell capsules, European Journal of Pharmaceutics and Biopharmaceutics, vol.53, issue.3, pp.327-360, 2002.
DOI : 10.1016/S0939-6411(02)00015-2

E. Gryczová, M. Rabi?ková, D. Vetchý, K. Krej?ová, and K. Krejcová, Pellet Starters in Layering Technique Using Concentrated Drug Solution, Drug Development and Industrial Pharmacy, vol.7, issue.12, pp.1381-1388, 2008.
DOI : 10.1201/b14855-2

R. Bodmeier, Tableting of coated pellets, European Journal of Pharmaceutics and Biopharmaceutics, vol.43, issue.1, pp.1-8, 1997.
DOI : 10.1016/S0939-6411(96)00028-8

S. Goskonda, G. Hileman, and S. Upadrashta, Development of Matrix Controlled Release Beads by Extrusion-Spheronization Technology Using a Statistical Screening Design, Drug Development and Industrial Pharmacy, vol.2, issue.3, pp.279-92, 1994.
DOI : 10.3109/03639048609065848

E. Hamedelniel, J. Bajdik, and K. Pintye-hódi, Optimization of preparation of matrix pellets containing ethylcellulose, Chemical Engineering and Processing: Process Intensification, vol.49, issue.1, pp.120-124, 2010.
DOI : 10.1016/j.cep.2009.12.002

M. Abbaspour, F. Sadeghi, and H. Garekani, Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination, International Journal of Pharmaceutics, vol.303, issue.1-2, pp.88-94, 2005.
DOI : 10.1016/j.ijpharm.2005.07.016

J. Kauffman, L. Batykefer, and D. Tuschel, Raman detected differential scanning calorimetry of polymorphic transformations in acetaminophen, Journal of Pharmaceutical and Biomedical Analysis, vol.48, issue.5, pp.1310-1315, 2008.
DOI : 10.1016/j.jpba.2008.09.008

P. Espeau, R. Céolin, J. Tamarit, M. Perrin, J. Gauchi et al., Polymorphism of paracetamol: Relative stabilities of the monoclinic and orthorhombic phases inferred from topological pressure???temperature and temperature???volume phase diagrams, Journal of Pharmaceutical Sciences, vol.94, issue.3, pp.524-563, 2005.
DOI : 10.1002/jps.20261

D. Raut, R. Allada, K. V. Pavan, G. Deshpande, D. Patil et al., Dehydration of Lactose monohydrate: Analytical and physical characterization, Der Pharm Lett, vol.3, issue.5, pp.202-214, 2011.

Á. Gombás, P. Szabó-révész, M. Kata, R. G. Jr, and I. Er?s, Quantitative Determination of Crystallinity of ?-Lactose Monohydrate by DSC, Journal of Thermal Analysis and Calorimetry, vol.68, issue.2, pp.503-513, 2002.
DOI : 10.1023/A:1016039819247

R. Mallipeddi, K. Saripella, and S. Neau, Use of fine particle ethylcellulose as the diluent in the production of pellets by extrusion-spheronization, Saudi Pharmaceutical Journal, vol.22, issue.4, pp.360-72, 2014.
DOI : 10.1016/j.jsps.2013.11.001

A. Agrawal, M. Howard, and S. Neau, Extruded and Spheronized Beads Containing No Microcrystalline Cellulose: Influence of Formulation and Process Variables, Pharmaceutical Development and Technology, vol.232, issue.8, pp.197-217, 2004.
DOI : 10.1016/S0378-5173(01)00908-5

C. Maderuelo, A. Zarzuelo, and J. Lanao, Critical factors in the release of drugs from sustained release hydrophilic matrices, Journal of Controlled Release, vol.154, issue.1, pp.2-19, 2011.
DOI : 10.1016/j.jconrel.2011.04.002

B. Ivi?, S. Ibri?, G. Betz, and Z. Djuri?, Evaluation of Diclofenac Sodium Release from Matrix Pellets Compressed into MUPS Tablets, YAKUGAKU ZASSHI, vol.129, issue.11, pp.1375-84, 2009.
DOI : 10.1248/yakushi.129.1375

J. Krause and J. Breitkreutz, Improving Drug Delivery in Paediatric Medicine, Pharmaceutical Medicine, vol.8, issue.2, pp.41-50, 2008.
DOI : 10.1016/j.prrv.2007.02.005

S. Gittings, N. Turnbull, C. Roberts, and P. Gershkovich, Dissolution methodology for taste masked oral dosage forms, Journal of Controlled Release, vol.173, pp.32-42, 2014.
DOI : 10.1016/j.jconrel.2013.10.030

M. Pein, M. Preis, C. Eckert, and F. Kiene, Taste-masking assessment of solid oral dosage forms???A critical review, International Journal of Pharmaceutics, vol.465, issue.1-2, pp.239-54, 2014.
DOI : 10.1016/j.ijpharm.2014.01.036

N. Shet and I. Vaidya, Taste masking: A pathfinder for bitter drugs, Int J Pharm Sci Rev Res, vol.18, issue.2, pp.1-12, 2013.

B. Albertini, C. Cavallari, N. Passerini, D. Voinovich, M. González-rodrí-guez et al., Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer, European Journal of Pharmaceutical Sciences, vol.21, issue.2-3, pp.295-303, 2004.
DOI : 10.1016/j.ejps.2003.10.017

H. Thi, T. Morel, S. Ayouni, F. Flament, and M. , Development and evaluation of tastemasked drug for paediatric medicines -Application to acetaminophen, Int J Pharm, vol.434, issue.12, pp.235-277, 2012.

T. Sam, T. Ernest, J. Walsh, and J. Williams, A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms ??? An application for paediatric dosage form selection, International Journal of Pharmaceutics, vol.435, issue.2, pp.115-138, 2012.
DOI : 10.1016/j.ijpharm.2012.05.024

E. Schornick, E. Kalivoda, A. Ognibene, and R. , Guideline on Pharmaceutical Development of Medicines for Paediatric Use. Reproduction Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms?, Pharm Dev Technol, vol.19, issue.3, pp.257-62, 2011.

D. Douroumis, A. Gryczke, and S. Schminke, Development and Evaluation of Cetirizine HCl Taste-Masked Oral Disintegrating Tablets, AAPS PharmSciTech, vol.12, issue.1, pp.141-51, 2011.
DOI : 10.1208/s12249-010-9569-7
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066355

C. Ferrero, N. Muñoz, M. V. Velasco, A. Muñoz-ruiz, and R. Jiménez-castellanos, Disintegrating efficiency of croscarmellose sodium in a direct compression formulation, International Journal of Pharmaceutics, vol.147, issue.1, pp.11-21, 1997.
DOI : 10.1016/S0378-5173(96)04784-9

S. Mehta, D. Beer, T. Remon, J. Vervaet, and C. , Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules, International Journal of Pharmaceutics, vol.422, issue.1-2, pp.310-317, 2012.
DOI : 10.1016/j.ijpharm.2011.11.017

T. Beckert, K. Lehmann, and P. Schmidt, Compression of enteric-coated pellets to disintegrating tablets: uniformity of dosage units, Powder Technology, vol.96, issue.3, pp.248-54, 1998.
DOI : 10.1016/S0032-5910(97)03380-9

M. Flament, P. Leterme, A. Gayot, E. Gendrot, and E. Bruna, Development and industrial scaleup of tablets containing modified-release pellets, Pharm Technol Eur, vol.2, pp.19-25, 1994.

V. Parkash, . Deepika, . Hemlata, S. Maan, S. Yadav et al., Fast disintegrating tablets: Opportunity in drug delivery system, Journal of Advanced Pharmaceutical Technology & Research, vol.2, issue.4, p.223, 2011.
DOI : 10.4103/2231-4040.90877
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255350

S. Pasha, N. Vamsi, S. Muddasar, and S. Vemireddy, Orodispersible tablets: a novel approach, Int J Biol Pharm Res, vol.4, issue.6, pp.402-413, 2013.

Y. Bi, H. Sunada, Y. Yonezawa, and K. Danjo, Evaluation of Rapidly Disintegrating Tablets Prepared by a Direct Compression Method, Drug Development and Industrial Pharmacy, vol.48, issue.10, pp.571-81, 1999.
DOI : 10.3109/03639049309047189

S. Jeong, J. Lee, and J. Woo, Fast Disintegrating Tablets, pp.155-67, 2010.
DOI : 10.1016/0378-5173(87)90056-1

A. Abdelbary, A. Elshafeey, and G. Zidan, Comparative effects of different cellulosic-based directly compressed orodispersable tablets on oral bioavailability of famotidine, Carbohydrate Polymers, vol.77, issue.4, pp.799-806, 2009.
DOI : 10.1016/j.carbpol.2009.02.030

A. Al-khattawi and A. Mohammed, Challenges and emerging solutions in the development of compressed orally disintegrating tablets, Expert Opinion on Drug Discovery, vol.11, issue.10, pp.1109-1129, 2014.
DOI : 10.1248/bpb.b13-00353

A. Lundqvist and F. Podczeck, Influence of disintegrant type and proportion on the properties of tablets produced from mixtures of pellets, International Journal of Pharmaceutics, vol.147, issue.1, pp.95-107, 1997.
DOI : 10.1016/S0378-5173(96)04800-4

R. Pabari and Z. Ramtoola, Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets, Journal of Young Pharmacists, vol.4, issue.3, pp.157-63, 2012.
DOI : 10.4103/0975-1483.100021

A. Gryczke, S. Schminke, M. Maniruzzaman, J. Beck, and D. Douroumis, Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion, Colloids and Surfaces B: Biointerfaces, vol.86, issue.2, pp.275-84, 2011.
DOI : 10.1016/j.colsurfb.2011.04.007

D. Douroumis, Orally disintegrating dosage forms and taste-masking technologies, 2010.
DOI : 10.1517/17425247.2011.566553

B. Badgujar, A. Mundada, A. Bashaiwoldu, F. Podczeck, M. Newton et al., The technologies used for developing orally disintegrating 59 Compaction of and drug release from coated pellets of different mechanical properties, Adv Powder Technol. The Society of Powder Technology Japan, vol.22, issue.3, pp.340-53, 2011.

A. Bowles, J. Keane, T. Ernest, D. Clapham, and C. Tuleu, Specific aspects of gastro-intestinal transit in children for drug delivery design, International Journal of Pharmaceutics, vol.395, issue.1-2, pp.37-43, 2010.
DOI : 10.1016/j.ijpharm.2010.04.048

X. Pan, M. Chen, K. Han, X. Peng, X. Wen et al., Novel compaction techniques with pellet-containing granules, European Journal of Pharmaceutics and Biopharmaceutics, vol.75, issue.3, pp.436-478, 2010.
DOI : 10.1016/j.ejpb.2010.04.011

M. Siewer, J. Dressman, C. Brown, V. Shah, and . Fip, AAPS Guidelines to Dissolution / in Vitro Release Testing of Novel / Special Dosage Forms *, AAPS PharmSciTech, vol.4, issue.1, pp.1-10, 2003.

G. Petrovick, J. Breitkreutz, and M. Pein-hackelbusch, Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization, International Journal of Pharmaceutics, vol.506, issue.1-2, pp.361-70, 2016.
DOI : 10.1016/j.ijpharm.2016.04.058

F. Liu, S. Ranmal, H. Batchelor, M. Orlu-gul, T. Ernest et al., Formulation factors affecting acceptability of oral medicines in children, International Journal of Pharmaceutics, vol.492, issue.1-2, pp.341-344, 2015.
DOI : 10.1016/j.ijpharm.2015.05.013

F. Lopez, T. Ernest, C. Tuleu, and M. Gul, Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms, Expert Opinion on Drug Delivery, vol.2012, issue.3, pp.1727-1767, 2015.
DOI : 10.1016/j.ijpharm.2014.03.053

D. Gaber, N. Nafee, and O. Abdallah, Mini-tablets versus pellets as promising multiparticulate modified release delivery systems for highly soluble drugs, International Journal of Pharmaceutics, vol.488, issue.1-2, pp.86-94, 2015.
DOI : 10.1016/j.ijpharm.2015.04.021

F. Otero-espinar, A. Luzardo-alvarez, and J. Blanco-méndez, Non-MCC materials as extrusion-spheronization aids in pellets production, Journal of Drug Delivery Science and Technology, vol.20, issue.4, pp.303-321, 2010.
DOI : 10.1016/S1773-2247(10)50047-9

H. Thi, T. Lhafidi, S. Carneiro, S. Flament, and M. , Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for pediatric use

A. Goyanes, C. Souto, and R. Martínez-pacheco, Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization, Pharmaceutical Development and Technology, vol.2, issue.6, pp.626-661, 2010.
DOI : 10.1016/S0928-0987(99)00004-4

K. V. Sirisha, K. Vijaya-sri, K. Suresh, K. Reddy, and G. , Multiple Unit pellets systems: a review, Int J Pharm, vol.2, issue.2, pp.419-444, 2012.

C. Iv, . And, and . Conclusion, References 1. World Health Organization. Development of Paediatric Medicines: Points to Consider in Formulation, 2012.

V. Yewale and D. Dharmapalan, Promoting Appropriate Use of Drugs in Children, International Journal of Pediatrics, vol.25, issue.1, pp.1-5, 2012.
DOI : 10.1001/archpedi.161.3.282

J. Mason, M. Pirmohamed, and T. Nunn, Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature, European Journal of Clinical Pharmacology, vol.58, issue.1, pp.21-29, 2012.
DOI : 10.1007/s00228-002-0554-2

C. Pandolfini and M. Bonati, A literature review on off-label drug use in children, European Journal of Pediatrics, vol.8, issue.9, pp.552-560, 2005.
DOI : 10.1136/bmj.316.7128.343

P. Auby, Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective, Child and Adolescent Psychiatry and Mental Health, vol.2, issue.1, p.38, 2008.
DOI : 10.1001/jama.297.5.480

A. Raymond and . Saint, Regulatory aspects of drug development in children: change and resistance to change, Expert Review of Clinical Pharmacology, vol.64, issue.5, pp.593-598, 2010.
DOI : 10.1001/jama.297.5.480

D. Knoppert, Pediatric Formulations, Pediatric Drugs, vol.10, issue.3, pp.55-61, 2009.
DOI : 10.2165/0148581-200911010-00018

T. Ernest, D. Elder, L. Martini, M. Roberts, and J. Ford, Developing paediatric medicines: identifying the needs and recognizing the challenges, Journal of Pharmacy and Pharmacology, vol.26, issue.6403, pp.1043-55, 2007.
DOI : 10.2165/00002018-200326080-00001

C. Tuleu and J. Breitkreutz, Educational Paper: Formulation-related issues in pediatric clinical pharmacology, European Journal of Pediatrics, vol.10, issue.2, pp.717-737, 2013.
DOI : 10.1517/14740338.2011.565328

J. Conway, L. Bero, C. Ondari, and K. Wasan, Review of the Quality of Pediatric Medications in Developing Countries, Journal of Pharmaceutical Sciences, vol.102, issue.5, pp.1419-1452, 2013.
DOI : 10.1002/jps.23474

R. Strickley, Q. Iwata, S. Wu, and T. Dahl, Pediatric Drugs-A Review of Commercially Available Oral Formulations, Journal of Pharmaceutical Sciences, vol.97, issue.5, pp.1731-74, 2008.
DOI : 10.1002/jps.21101

E. Fernandez, R. Perez, A. Hernandez, P. Tejada, M. Arteta et al., Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults, Pharmaceutics, vol.264, issue.4, pp.53-72, 2011.
DOI : 10.1016/S0009-8981(97)00086-7
URL : http://doi.org/10.3390/pharmaceutics3010053

S. Abdel-rahman, G. Amidon, A. Kaul, V. Lukacova, A. Vinks et al., Summary of the National Institute of Child Health and Human Development???Best Pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop???Pediatric Biopharmaceutics Classification System Working Group, Clinical Therapeutics, vol.34, issue.11, pp.11-24, 2012.
DOI : 10.1016/j.clinthera.2012.09.014

D. Elder, M. Kuentz, and R. Holm, Pharmaceutical excipients ??? quality, regulatory and biopharmaceutical considerations, European Journal of Pharmaceutical Sciences, vol.87, pp.88-97, 2016.
DOI : 10.1016/j.ejps.2015.12.018

B. Garcia-palop, M. Polanco, E. , C. Ramirez, C. et al., Harmful excipients in medicines for neonates in Spain, International Journal of Clinical Pharmacy, vol.173, issue.2, pp.238-280, 2016.
DOI : 10.1007/s00431-014-2272-z

V. Fabiano, C. Mameli, and G. Zuccotti, Paediatric pharmacology: Remember the excipients, Pharmacological Research, vol.63, issue.5
DOI : 10.1016/j.phrs.2011.01.006

H. Kristensen, WHO guideline development of paediatric medicines: Points to consider in pharmaceutical development, International Journal of Pharmaceutics, vol.435, issue.2, pp.134-51, 2011.
DOI : 10.1016/j.ijpharm.2012.05.054

. Emea, Guideline on Pharmaceutical Development of Medicines for Paediatric Use. Reproduction Available from, 2011.

J. Wang, D. Avant, D. Green, S. Seo, J. Fisher et al., A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development, Clinical Pharmacology & Therapeutics, vol.168, issue.3, pp.328-363, 2015.
DOI : 10.1001/jamapediatrics.2013.4208

F. Rocchi and P. Tomasi, The development of medicines for children, Pharmacological Research, vol.64, issue.3, pp.169-75, 2011.
DOI : 10.1016/j.phrs.2011.01.016

A. Ali, N. Charoo, and D. Abdallah, Pediatric drug development: formulation considerations, Drug Development and Industrial Pharmacy, vol.67, issue.10, pp.1-17, 2014.
DOI : 10.1016/j.ejpb.2012.01.014

J. Breitkreutz and J. Boos, Paediatric and geriatric drug delivery, Expert Opinion on Drug Delivery, vol.67, issue.1, pp.37-45, 2007.
DOI : 10.1055/s-2005-870129

S. Montero-padilla, S. Velaga, and J. Morales, Buccal Dosage Forms: General Considerations for Pediatric Patients, AAPS PharmSciTech, vol.18, issue.2, pp.1-10, 2016.
DOI : 10.1208/s12249-016-0567-2

V. Ivanovska, C. Rademaker, L. Van-dijk, and A. Mantel-teeuwisse, Pediatric Drug Formulations: A Review of Challenges and Progress, PEDIATRICS, vol.134, issue.2, pp.361-72, 2014.
DOI : 10.1542/peds.2013-3225

J. Krause and J. Breitkreutz, Improving Drug Delivery in Paediatric Medicine, Pharmaceutical Medicine, vol.8, issue.2, pp.41-50, 2008.
DOI : 10.1016/j.prrv.2007.02.005

T. Nunn and J. Williams, Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-680, 2005.
DOI : 10.1111/j.1365-2125.2005.02410.x

S. V. Gandhi, W. Rodriguez, M. Khan, and J. Polli, Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs, AAPS PharmSciTech, vol.15, issue.3, pp.601-612, 2014.
DOI : 10.1208/s12249-014-0084-0
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037489

H. Batchelor and J. Marriott, Formulations for children: problems and solutions, British Journal of Clinical Pharmacology, vol.97, issue.S2, pp.405-423, 2015.
DOI : 10.1136/archdischild-2011-300909
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345951

. Emea, Reflection Paper : Formulations of Choice for the Paediatric Population Available from, 2006.

S. Maldonado and D. Schaufelberger, Pediatric formulations. American Pharmaceutical Review, pp.1-5, 2011.

A. Lajoinie, E. Henin, and B. Kassai, Choisir la forme pharmaceutique orale la plus adapt??e ?? l???enfant, Archives de P??diatrie, vol.22, issue.8, pp.877-85, 2015.
DOI : 10.1016/j.arcped.2015.05.012

N. Spomer, V. Klingmann, I. Stoltenberg, C. Lerch, T. Meissner et al., Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study, Archives of Disease in Childhood, vol.97, issue.3, pp.283-289, 2012.
DOI : 10.1136/archdischild-2011-300958

H. Kyngäs, T. Kroll, and M. Duffy, Compliance of adolescents with chronic disease, Journal of Clinical Nursing, vol.13, issue.4, pp.379-88, 2000.
DOI : 10.1046/j.1365-2648.1993.18010103.x

F. Varum, H. Merchant, and A. Basit, Oral modified-release formulations in motion: The relationship between gastrointestinal transit and drug absorption, International Journal of Pharmaceutics, vol.395, issue.1-2, pp.26-36, 2010.
DOI : 10.1016/j.ijpharm.2010.04.046

M. Flament, Extended-release dosage: recent advances and potential in pediatric medicine, Therapeutic Delivery, vol.7, issue.4
DOI : 10.4155/tde.16.2

M. Buck and D. Pharm, Alternative forms of oral drug delivery for pediatric patients, Pediatric Pharmacotherapy, vol.19, issue.3, pp.1-4, 2013.

A. Dashevsky, K. Kolter, and R. Bodmeier, Compression of pellets coated with various aqueous polymer dispersions, International Journal of Pharmaceutics, vol.279, issue.1-2, pp.19-26, 2004.
DOI : 10.1016/j.ijpharm.2004.03.019

S. Azarmi, F. Ghaffari, R. Löbenberg, and A. Nokhodchi, Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices, Il Farmaco, vol.60, issue.11-12, pp.925-955, 2005.
DOI : 10.1016/j.farmac.2005.07.009

Q. Cao, Y. Choi, J. Cui, and B. Lee, Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen, Journal of Controlled Release, vol.108, issue.2-3, pp.351-61, 2005.
DOI : 10.1016/j.jconrel.2005.08.004